Related Experiment Video
Updated: Sep 26, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention
Wenguang Lai1,2,3, Xiaoli Zhao4, Sijia Yu2,3,5
1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Insights
Chronic kidney disease (CKD) significantly increases the risk of developing heart failure with reduced ejection fraction (HFrEF) after percutaneous coronary intervention (PCI). This association highlights the need for proactive management in CKD patients undergoing PCI to prevent HFrEF and reduce mortality.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- Chronic kidney disease (CKD) is prevalent in patients at high risk for heart failure with reduced ejection fraction (HFrEF).
- The impact of CKD on incident HFrEF in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains understudied.
Purpose of the Study:
- To investigate the association between chronic kidney disease (CKD) and the incidence of heart failure with reduced ejection fraction (HFrEF).
- To examine the impact of CKD on all-cause mortality in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).
Main Methods:
- A cohort of 2,356 patients with baseline left ventricular ejection fraction (LVEF) ≥ 40% undergoing PCI between January 2007 and December 2018 was analyzed.
- Incident HFrEF was defined as a follow-up LVEF < 40% within 3-12 months post-discharge.
- Multivariable logistic regression was employed to assess the relationship between CKD and incident HFrEF, adjusting for multiple confounders.
Main Results:
- Of the 2,356 patients, 18.5% had CKD, and 3.5% developed incident HFrEF.
- The incidence of HFrEF was significantly higher in the CKD group (6.9%) compared to the non-CKD group (2.8%; p < 0.001).
- CKD was identified as an independent risk factor for incident HFrEF (aOR = 1.75; p = 0.035), and patients with incident HFrEF had higher all-cause mortality (26.5% vs. 8.1%; p < 0.001).
Conclusions:
- CKD is independently associated with an increased risk of developing HFrEF following PCI in patients with CAD.
- The presence of CKD in patients undergoing PCI is linked to higher all-cause mortality.
- Implementing more aggressive preventive strategies for HFrEF is crucial for patients with CKD undergoing PCI.
Background:
Chronic kidney disease (CKD) is very common in patients who are at a high risk of developing incident heart failure with reduced ejection fraction (HFrEF). However, the harmful effect of CKD on incident HFrEF has not yet been examined among patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).
Methods:
Patients undergoing PCI with baseline left ventricular ejection fraction (LVEF) ≥ 40% were included from January 2007 to December 2018 (ClinicalTrials.gov NCT04407936). We defined incident HFrEF as a follow-up LVEF of <40% within 3-12 months after discharge. Multivariable logistical regression was performed to examine the association of CKD with incident HFrEF.
Results:
Overall, of 2,356 patients (mean age 62.4 ± 10.7 years, 22.2% women), 435 (18.5%) had CKD, and 83 (3.5%) developed incident HFrEF following PCI. The rate of incident HFrEF in the CKD group was higher than that in the non-CKD group (6.9 vs. 2.8%; p < 0.001). Multivariate logistic regression analysis indicated that CKD was an independent risk factor of incident HFrEF [adjusted odds ratio (aOR) = 1.75; 95% CI, 1.03-2.92; p = 0.035] after adjustment for confounders including age, gender, diabetes, hypertension, atrial fibrillation, congestive heart failure (CHF), baseline LVEF, ACEI/ARB, and statins. Furthermore, patients with incident HFrEF have a higher ratio of all-cause mortality compared to those without HFrEF (26.5 vs. 8.1%; p < 0.001).
Conclusions:
Our results suggested that CKD was associated with increased risk of incident HFrEF, which was related to higher all-cause mortality in patients with CAD undergoing PCI. On this basis, more aggressive measures should be taken to prevent patients with CKD undergoing PCI from developing HFrEF.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

